Atlas Venture Associates XI, L.P.
CIK 000178006810% Owner
Filings
5
Latest Feb 28, 2024
Issuers covered
2
Showing
5 of 5
Page 1
Issuers
Companies where Atlas Venture Associates XI, L.P. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | 3 | Feb 28, 2024 |
| XLO | Xilio Therapeutics, Inc. | 2 | Feb 9, 2024 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Issuer | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Feb 28, 2024 | DYNDyne Therapeutics, Inc. | S | 272,923 | $24.38 | $6,653,863 | |
| Feb 23, 2024 | DYNDyne Therapeutics, Inc. | S | 159,542 | $22.70 | $3,621,603 | |
| Feb 20, 2024 | DYNDyne Therapeutics, Inc. | S | 175,793 | $23.88 | $4,197,937 | |
| Feb 9, 2024 | XLOXilio Therapeutics, Inc. | S | 733 | $0.64 | $469 | |
| Jan 16, 2024 | XLOXilio Therapeutics, Inc. | S | 1,566 | $0.87 | $1,362 |
Showing 1–5 of 5
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.